No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric staphylococcus aureus blood isolates

Pediatric Infectious Disease Journal

Volumn 33, Issue 2, 2014, Pages 216-218

  Goldman, Jennifer L ^a,b   Harrison, Christopher J ^a,b   Myers, Angela L ^a,b   Jackson, Mary Anne ^a,b   Selvarangan, Rangaraj ^a,b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

heteroresistance; resistance; Staphylococcus aureus; vancomycin

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BROTH DILUTION; EPSILOMETER TEST; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84893014356     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/01.inf.0000436281.18687.0c     Document Type: Article

References (11)

1. Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis. 2009;4965-71
2. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from2001-05. J Antimicrob Chemother. 2007;60788-794
3. Kullar R, Davis SL, Levine DP, et al. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia support for consensus guidelines suggested targets. Clin Infect Dis. 2011;52975-981
4. Soriano A, Marco F, Martínez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46193-200
5. Lodise TP, Graves J, Evans A, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother. 2008;523315-3333
6. Mason EO, Lamberth LB, Hammerman WA, et al. Vancomycin MICs for Staphylococcus aureus vary by detection method and hae subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009;471628-1630
7. Zheng X, Qi C, Arrieta M, et al. Lack of increase in vancomycin resistance of pediatric methicillin-resistant Staphylococcus aureus Isolates from 2000to 2007. Pediatr Infect Dis J. 2010;29882-884
8. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically M07-A8. Wayne, PA Clinical and Laboratory Standards Institute; 2009
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing 19th Informational Supplement M100-S19. Wayne, PA Clinical and Laboratory Standards Institue; 2009
10. Wang G, Hindler JF, Ward KW, et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a5-year period. J Clin Microbiol. 2006;443883-3886
11. Leonard SN, Rossi KL, Newton KL, et al. Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides. J Antimicrob Chemother. 2009;63489-492